| Primary |
| Induction Of Anaesthesia |
17.8% |
| Product Used For Unknown Indication |
16.1% |
| Anaesthesia |
13.0% |
| Neuromuscular Blocking Therapy |
10.2% |
| General Anaesthesia |
9.5% |
| Anaesthesia Procedure |
5.1% |
| Maintenance Of Anaesthesia |
5.1% |
| Muscle Relaxant Therapy |
4.4% |
| Surgery |
2.8% |
| Hypotonia |
2.5% |
| Endotracheal Intubation |
2.4% |
| Neuromuscular Blockade |
2.2% |
| Drug Use For Unknown Indication |
2.1% |
| Induction And Maintenance Of Anaesthesia |
1.6% |
| Sedation |
1.2% |
| Neuromuscular Blockade Reversal |
1.1% |
| Anaesthetic Premedication |
0.8% |
| Antibiotic Prophylaxis |
0.8% |
| Prophylaxis |
0.7% |
| Analgesic Therapy |
0.6% |
|
| Drug Ineffective |
11.3% |
| Tachycardia |
9.7% |
| Neuromuscular Block Prolonged |
9.2% |
| Cardiac Arrest |
8.8% |
| Urticaria |
7.6% |
| Drug Effect Decreased |
6.7% |
| Rhabdomyolysis |
5.5% |
| Anaphylactic Reaction |
4.6% |
| Product Quality Issue |
4.2% |
| Respiratory Arrest |
3.8% |
| Circulatory Collapse |
3.4% |
| Delayed Recovery From Anaesthesia |
3.4% |
| Ventricular Tachycardia |
3.4% |
| Dyspnoea |
2.9% |
| Hypotension |
2.9% |
| Procedural Complication |
2.9% |
| Pulmonary Oedema |
2.5% |
| Therapeutic Response Decreased |
2.5% |
| Tongue Oedema |
2.5% |
| Drug Effect Prolonged |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
24.7% |
| Drug Use For Unknown Indication |
15.6% |
| Anaesthesia |
11.5% |
| General Anaesthesia |
9.2% |
| Induction Of Anaesthesia |
8.0% |
| Maintenance Of Anaesthesia |
5.7% |
| Ill-defined Disorder |
5.2% |
| Anaesthesia Procedure |
2.5% |
| Infection |
2.2% |
| Constipation |
2.0% |
| Sedation |
2.0% |
| Pyrexia |
1.9% |
| Hypotonia |
1.5% |
| Prophylaxis |
1.5% |
| Induction And Maintenance Of Anaesthesia |
1.3% |
| Endotracheal Intubation |
1.1% |
| Preoperative Care |
1.1% |
| Muscle Relaxant Therapy |
1.0% |
| Pain |
1.0% |
| Neuromuscular Blockade Reversal |
1.0% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
13.9% |
| Anaphylactic Shock |
10.3% |
| Rhabdomyolysis |
8.5% |
| Tachycardia |
8.5% |
| Anaphylactic Reaction |
7.2% |
| Hypotension |
7.2% |
| White Blood Cell Count Increased |
4.9% |
| Stevens-johnson Syndrome |
4.5% |
| Pulmonary Oedema |
4.0% |
| Serotonin Syndrome |
3.6% |
| Toxic Skin Eruption |
3.6% |
| Ventricular Tachycardia |
3.6% |
| Drug Interaction |
3.1% |
| Drug Ineffective |
2.7% |
| Endotracheal Intubation Complication |
2.7% |
| Unresponsive To Stimuli |
2.7% |
| Cardiac Arrest |
2.2% |
| Drug Effect Decreased |
2.2% |
| Drug Effect Increased |
2.2% |
| Drug Exposure During Pregnancy |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.9% |
| Anaesthesia |
13.2% |
| Induction Of Anaesthesia |
11.6% |
| General Anaesthesia |
9.6% |
| Drug Use For Unknown Indication |
9.1% |
| Maintenance Of Anaesthesia |
8.4% |
| Prophylaxis |
5.7% |
| Analgesic Therapy |
3.7% |
| Surgery |
2.9% |
| Induction And Maintenance Of Anaesthesia |
2.5% |
| Pain |
2.1% |
| Hypertension |
2.1% |
| Anaesthesia Procedure |
1.7% |
| Hypotonia |
1.6% |
| Infection Prophylaxis |
1.6% |
| Sedation |
1.6% |
| Premedication |
1.5% |
| Supportive Care |
1.5% |
| Prophylaxis Of Nausea And Vomiting |
1.3% |
| Sedative Therapy |
1.3% |
|
| Ventricular Tachycardia |
10.3% |
| Serotonin Syndrome |
8.5% |
| Vomiting |
8.1% |
| Rhabdomyolysis |
6.6% |
| Cardiac Arrest |
6.3% |
| Ventricular Fibrillation |
5.9% |
| Bradycardia |
5.1% |
| Pain |
4.8% |
| Anaphylactic Shock |
4.4% |
| Hyperthermia Malignant |
4.4% |
| Hypotension |
4.0% |
| Stress Cardiomyopathy |
4.0% |
| Unevaluable Event |
4.0% |
| Injury |
3.7% |
| Pyrexia |
3.7% |
| Drug Interaction |
3.3% |
| Tachycardia |
3.3% |
| Unresponsive To Stimuli |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Anaphylactic Reaction |
2.9% |
|
| Interacting |
| General Anaesthesia |
25.0% |
| Breast Cancer |
8.3% |
| Dementia Alzheimer's Type |
8.3% |
| Prophylaxis Of Nausea And Vomiting |
8.3% |
| Thyroglossal Cyst Excision |
8.3% |
| Anaesthesia |
5.6% |
| Arrhythmia |
5.6% |
| Atrial Fibrillation |
5.6% |
| Induction And Maintenance Of Anaesthesia |
5.6% |
| Arrhythmia Prophylaxis |
2.8% |
| Hypertension |
2.8% |
| Induction Of Anaesthesia |
2.8% |
| Maintenance Of Anaesthesia |
2.8% |
| Muscle Relaxant Therapy |
2.8% |
| Osteomyelitis |
2.8% |
| Product Used For Unknown Indication |
2.8% |
|
| Neuromuscular Block Prolonged |
43.8% |
| Drug Interaction |
18.8% |
| Drug Effect Decreased |
6.3% |
| Extrasystoles |
6.3% |
| Hypotension |
6.3% |
| Potentiating Drug Interaction |
6.3% |
| Ventricular Fibrillation |
6.3% |
| Ventricular Tachycardia |
6.3% |
|
